<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Therapy of phlebothrombosis during pregnancy general is carried out with <z:chebi fb="5" ids="28304">heparin</z:chebi>, in which case the initial hospital treatment may be continued later on with subcutaneous applications of <z:chebi fb="5" ids="28304">heparin</z:chebi> in the out-patient department </plain></SENT>
<SENT sid="1" pm="."><plain>Regular clinical and apparative controls are performed during pregnancy within </plain></SENT>
<SENT sid="2" pm="."><plain>Low dose <z:chebi fb="5" ids="28304">heparin</z:chebi> is injected up to the optimal dicumarol blood level (beginning with the 2nd day post partum) immediately pre-, intra- and postpartelly </plain></SENT>
<SENT sid="3" pm="."><plain>- Coagulation analyses in 11 patients with former phlebothrombosis during pregnancy revealed no <z:hpo ids='HP_0001976'>antithrombin III-deficiency</z:hpo>, but hints to insufficient fibrinolysis in four cases </plain></SENT>
</text></document>